| General Information | |||
|---|---|---|---|
| Term | aspartylglucosaminuria | ID (Ontology) | DOID:0050461 (Human Disease) |
| Definition | A lysosomal storage disease that is characterized by delayed speech at 2-3 years of age, has_material_basis_in mutations in the AGA gene that result in the absence or shortage of the aspartylglucosaminidase enzyme in lysosomes, preventing the normal breakdown of glycoproteins. | ||
| Also Known As | "aspartylglucosaminidase deficiency" ; "aspartylglycosaminuria" ; "glycosylasparaginase deficiency" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
inherited metabolic disorder |__lysosomal storage disease |__aspartylglucosaminuria 3 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | lysosomal storage disease | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:5854 ICD10CM:E77.1 MESH:D054880 MIM:208400 NCI:C61273 SNOMEDCT_US_2023_03_01:54954004 UMLS_CUI:C0268225 |
|||